Ara-C

Drug identity checked against registry records

Also recorded as Cytarabine

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML PatientsNCT01838395BLRXPhase 2Completed2016-03Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.